Treatment News : Toward a Cure: Virologic Control Documented in 14 Acute HIV Treaters - by Tim Horn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » August 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


August 1, 2012

Toward a Cure: Virologic Control Documented in 14 Acute HIV Treaters

by Tim Horn

AIDS 2012A new study released Thursday, July 26, at the XIX International AIDS Conference (AIDS 2012) in Washington, DC, found that 14 people living with HIV have achieved long-term non-progressing “viral controller” status after being treated with antiretrovirals (ARVs) during the acute phase of their infections. The fact that these individuals have shown no signs of viral load rebounds following termination of their prescribed treatment regimens may ultimately provide guidance to scientists pursuing “functional” HIV cures.

The 14 individuals described at AIDS 2012 by Charline Bacchus, PhD, of the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) comprise the Virologic and Immunologic Studies in Controllers after Treatment Interruption (VISCONTI) cohort.

VISCONTI participants initiated ARV therapy within ten weeks of becoming infected with HIV and remained on treatment for roughly three years. They averaged 500 CD4 cells and viral loads of 100,000 copies upon starting treatment. Roughly six-and-a-half years after stopping treatment, the average CD4 cell count was 900 and all study subjects had viral loads below 50 copies.

"Six years after interruption of treatment, patients treated early on in the post-infection period present a perfect ability to control the HIV infection,” Bacchus said. She added that VISCONTI cohort participants also possess an extremely small reservoir of HIV in CD4 cells, similar to levels seen in “elite controllers” who spontaneously reduce their viral loads to undetectable levels without treatment.

Could it be that VISCONTI cohort participants would have been elite controllers without the use of ARVs? Not likely, Bacchus explained, as the patients’ human leukocyte (HLA) patterns—the genes related to immune function in humans—differ from those seen in individuals participating in untreated virologic controller cohorts.   

Bacchus noted that research is ongoing to explore the immunologic characteristics that allowed these patients to remain off treatment, without viral load rebounds.

Search: visconti, french, anrs, bacchus, functional cure, acute infection, treatment, arvs, aids 2012

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (14 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.